AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2018
Aug 6, 2018
31949_dirs_2018-08-06_c91620bc-708b-422a-8ebb-217a615653bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-07-25
Reporting Person: HILLEMAN JERYL L (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Ordinary Shares | $34.00 | 2028-07-30 | Ordinary Shares (37101) | Direct |
Footnotes
F1: This stock option will vest in equal parts on each of July 31, 2019, July 31, 2020 and July 31, 2021.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3